Loading
Sentiment · FY2026 Q4
As of FY2026 Q3, the Tellvest earnings-call sentiment score for Medtronic (MDT) is 7/10.
Revenue of $9 billion grew 6% organically, the highest organic growth in 10 quarters, with CAS surging 80% as PFA reached 80% of segment revenue and gained 4 points of market share. Hugo robotic platform completed its first U.S. cases at Cleveland Clinic while Stealth AXiS FDA clearance transformed the spine robotics platform. FY2026 EPS guidance was maintained at $5.62-$5.66.
Scored from Medtronic’s FY2026 Q3 earnings call. The newest quarter is available with Tellvest Pro.
Full Pro access for 30 days when you create a free account. No credit card required.
All prior quarters are free.
Reporting soon: earnings call Tuesday, Sep 1
A pre-earnings brief is ready for MDT: the setup, what peers and partners said this season, and which analysts to watch. Reading it is a Tellvest Pro feature.
| Quarter | Revenue | Rev YoY | EPS | EPS YoY | Gross margin | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|---|
| FY2025 Q1 | $7.92B | +2.8% | $0.80 | +35.6% | 65.1% | 16.1% | 13.2% | $466M |
| FY2025 Q2 | $8.40B | +5.2% | $0.99 | +45.6% | 64.9% | 19.0% | 15.1% | $554M |
| FY2025 Q3 | $8.29B | +2.5% | $1.01 | +2.0% | 66.5% | 19.9% | 15.6% | $2.10B |
| FY2025 Q4 | $8.93B | +3.9% | $0.82 | +67.3% | 64.7% | 16.1% | 11.8% | $2.07B |
| FY2026 Q1 | $8.58B | +8.4% | $0.81 | +1.3% | 57.7% | 16.8% | 12.1% | $584M |
| FY2026 Q2 | $8.96B | +6.6% | $1.07 | +8.1% | 60.3% | 18.8% | 15.3% | $457M |
| FY2026 Q3 | $9.02B | +8.8% | $0.89 | -11.9% | 64.9% | 19.7% | 12.7% | $2.30B |
| FY2026 Q4 | $9.81B | +9.9% | $0.96 | +17.1% | 75.9% | 19.1% | 12.7% | $2.08B |
| Year | Revenue | Rev YoY | EPS | EPS YoY | Gross margin | Op margin | Net margin | FCF |
|---|---|---|---|---|---|---|---|---|
| FY2023 | $31.23B | -1.4% | $2.82 | -24.4% | 65.7% | 17.6% | 12.0% | $4.58B |
| FY2024 | $32.36B | +3.6% | $2.75 | -2.5% | 65.3% | 15.9% | 11.4% | $5.20B |
| FY2025 | $33.54B | +3.6% | $3.62 | +31.6% | 65.3% | 17.8% | 13.9% |
| $5.18B |
| FY2026 | $36.36B | +8.4% | $3.73 | +3.0% | 65.0% | 18.6% | 13.2% | $5.43B |